Skip to content
healthcare.dev

LEVETIRACETAM

NDC 36000-265, levetiracetam, injection, solution, concentrate, from Baxter Healthcare Corporation.

Product NDC
36000-265
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208458
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/36000-265 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVETIRACETAM100 mg/mL

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
36000-265-05360000265055 VIAL, SINGLE-DOSE in 1 CARTON (36000-265-05) / 5 mL in 1 VIAL, SINGLE-DOSE (36000-265-01)
36000-265-103600002651010 VIAL, SINGLE-DOSE in 1 CARTON (36000-265-10) / 5 mL in 1 VIAL, SINGLE-DOSE (36000-265-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8e381590-1147-46f3-9cbd-dc9716013444

Use it

Look up 36000-265 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/36000-265 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 36000-265. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.